Family Legacy Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,564 shares of the healthcare conglomerate’s stock after selling 228 shares during the period. Family Legacy Inc.’s holdings in UnitedHealth Group were worth $1,217,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the last quarter. Kings Point Capital Management raised its holdings in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the last quarter. Founders Capital Management purchased a new stake in shares of UnitedHealth Group in the first quarter valued at about $135,000. Parkside Financial Bank & Trust raised its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the last quarter. Finally, Hanson McClain Inc. raised its holdings in shares of UnitedHealth Group by 1.7% in the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The disclosure for this sale can be found here. Over the last three months, insiders sold 76,174 shares of company stock worth $14,981,909. 0.89% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: This article was first published by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dailypolitical.com/2017/09/21/family-legacy-inc-trims-stake-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $1.96 earnings per share.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.

UNH has been the subject of a number of research reports. Morgan Stanley upped their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Deutsche Bank AG upped their target price on shares of UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, July 13th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, Citigroup Inc. upped their target price on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. One investment analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $203.41.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.